Hylapharm

HylaPharm is a university spinout company based in Lawrence, Kansas, focused on developing innovative cancer therapies that have shown promising immune responses in real cancers in pet dogs. Their mission is to reverse tumor-induced immune suppression, enhancing the effectiveness of treatments for both animals and humans, particularly in fortifying responses to checkpoint inhibitors.

The company has made significant progress, including the successful treatment of pet dogs with mast cell cancer and the acquisition of multiple grants to support their research initiatives. With a dedicated team based at the BTBC incubator, HylaPharm is at the forefront of cancer research and treatment advancement in both veterinary and human medicine.

Generated from the website